INVO
Price:
$0.833
Market Cap:
$3.25M
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.[Read more]
Industry
Medical - Devices
IPO Date
2020-11-02
Stock Exchange
NASDAQ
Ticker
INVO
According to INVO Bioscience, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.69M. This represents a change of -16.68% compared to the average of 9.23M of the last 4 quarters.
The mean historical Enterprise Value of INVO Bioscience, Inc. over the last ten years is 7.19M. The current 7.69M Enterprise Value has changed 10.60% with respect to the historical average. Over the past ten years (40 quarters), INVO's Enterprise Value was at its highest in in the June 2021 quarter at 43.62M. The Enterprise Value was at its lowest in in the June 2015 quarter at 0.
Average
7.19M
Median
3.98M
Minimum
898.28K
Maximum
31.84M
Discovering the peaks and valleys of INVO Bioscience, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 701.68%
Maximum Annual Enterprise Value = 31.84M
Minimum Annual Increase = -75.78%
Minimum Annual Enterprise Value = 898.28K
Year | Enterprise Value | Change |
---|---|---|
2023 | 10.57M | 36.96% |
2022 | 7.71M | -75.78% |
2021 | 31.84M | 342.20% |
2020 | 7.20M | 701.68% |
2019 | 898.28K | -73.76% |
2018 | 3.42M | 141.43% |
2017 | 1.42M | -46.70% |
2016 | 2.66M | -41.23% |
2015 | 4.53M | 182.53% |
2014 | 1.60M | 135.22% |
The current Enterprise Value of INVO Bioscience, Inc. (INVO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
16.71M
5-year avg
11.64M
10-year avg
7.19M
INVO Bioscience, Inc.’s Enterprise Value is less than Entera Bio Ltd. (56.58M), greater than NLS Pharmaceutics AG (7.14M), greater than Enveric Biosciences, Inc. (883.37K), greater than Lixte Biotechnology Holdings, Inc. (1.95M), less than CLPS Incorporation (37.83M),
Company | Enterprise Value | Market cap |
---|---|---|
56.58M | $65.38M | |
7.14M | $5.97M | |
883.37K | $4.39M | |
1.95M | $4.54M | |
37.83M | $43.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like INVO Bioscience, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like INVO Bioscience, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is INVO Bioscience, Inc.'s Enterprise Value?
What is the highest Enterprise Value for INVO Bioscience, Inc. (INVO)?
What is the 3-year average Enterprise Value for INVO Bioscience, Inc. (INVO)?
What is the 5-year average Enterprise Value for INVO Bioscience, Inc. (INVO)?
How does the current Enterprise Value for INVO Bioscience, Inc. (INVO) compare to its historical average?